APRETUDE

Google image searchProduct monograph

Active ingredient

cabotegravir, 200 MG/ML

DIN: 02547473

Dosage form(s): SUSPENSION (EXTENDED-RELEASE)

Route(s) of administration: INTRAMUSCULAR

Schedule: Prescription

Company: VIIV HEALTHCARE ULC

Date: 19-JUN-2024

ATC:

Reference brand drug: Apretude, Vocabria

Search on Google